CEO Total Pay
$12.3M
FY2024 Summary Compensation, above median
SMG FY2024 SEC EDGAR DEF 14A
Scotts Miracle-gro Co CEO pay ratio
The CEO earned $12.3M in FY2024 against median worker pay of $66,696 · Chemicals & Pharmaceuticals.
- State
- OH
- Filing date
- 2025-12-17
- Industry
- Chemicals & Pharmaceuticals
- Fiscal year
- FY2024
Data updated August 2026
Subscribe to Scotts Miracle-gro Co CEO pay filing updates (RSS)
CEO-to-worker pay ratio
184:1
High (Scale: 0–1000:1)
CEO pay
$12.3M
Median worker
$66,696
Latest filing FY2024. This company's newest DEF 14A on file is for FY2024, not FY2025, so the figures on this page are from that earlier year and are not ranked against the FY2025 industry benchmark. Industry pages mark issuers like this one with a "Latest filing" label.
Answer first
Scotts Miracle-gro Co reported a 184:1 CEO-to-worker pay ratio in FY2024 - above the Chemicals & Pharmaceuticals median of 42:1 across 168 filers.
Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.
- Pay ratio
- 184:1
- FY2024 disclosed
- CEO total
- $12.3M
- Summary Compensation Table total
- Median worker
- $66,696
- Dodd-Frank median employee
Ratio bands among Chemicals & Pharmaceuticals peers
Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.
CEO Compensation Breakdown, FY2024
A component-level pay breakdown is not reported in Scotts Miracle-gro Co's structured SEC pay-ratio disclosure. See our methodology →
Filing-year trail · Scotts Miracle-gro Co
Complete DEF 14A pay-ratio filings for this CIK across FY2021–2024. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).
- Latest ratio
- 184:1
- FY2024
- vs prior FY
- -80:1
- from FY2023 264:1
- CEO $ YoY
- -19%
- $12.3M latest
- Filings shown
- 4
- FY2021–2024
| FY | CEO pay | Δ pay | Median worker | Pay ratio | Δ ratio |
|---|---|---|---|---|---|
| 2021 | $8.2M | - | $61,592 | 133:1 | - |
| 2022 | $12.0M | +47% | $58,683 | 204:1 | +71:1 |
| 2023 | $15.2M | +27% | $57,810 | 264:1 | +60:1 |
| 2024 | $12.3M | -19% | $66,696 | 184:1 | -80:1 |
Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 825542, FY2021–2024. Adjacent-year deltas only.
Industry Comparison - Chemicals & Pharmaceuticals
This Company's Ratio
184:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$12.3M
Companies in Industry
168
vs. Industry Median
Above
Scotts Miracle-gro Co: STEEP · HEAVY pay ratio
Scotts Miracle-gro Co disclosed 184:1 CEO-to-worker pay and $12.3M CEO total in FY2024. the CEO earned 184× the median employee ($66,696) in FY2024.
Median employee $66,696 (PAR-MED); STEEP · HEAVY stamps put about 184 median-wage years per CEO year.
Pay Ratio
184:1
Elevated vs. peers
What FY2024 shows for Scotts Miracle-gro Co
Scotts Miracle-gro Co disclosed 184:1 CEO-to-worker pay and $12.3M CEO total in FY2024. The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Scotts Miracle-gro Co's $12.3M CEO total is above the $7.9M industry median CEO pay.
Scotts Miracle-gro Co stamps STEEP · HEAVY · PAR-MED; grant-date fair value (not realized pay) is what the DEF 14A reports. Open Chemicals & Pharmaceuticals peers.
Key Data, FY2024
- Total Compensation
- $12.3M
- Median Employee Pay
- $66,696
- Pay Ratio
- 184:1
- Filing Date
- 2025-12-17
Company Info
- Ticker
- SMG
- CIK
- 825542
- Industry
- Chemicals & Pharmaceuticals
- SIC Code
- 2870
- State
- OH
SEC EDGAR DEF 14A for CIK 825542, FY2024. Informational only, not investment advice. Verify on EDGAR.
Read our methodology - how this data is sourced, computed, and verified. Scotts Miracle-gro Co disclosed 184:1 CEO-to-worker pay and $12.3M CEO total in FY2024.
Read with Scotts Miracle-gro Co
ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps STEEP · HEAVY · PAR-MED.
Centuri Holdings, Inc. · HEAVY
ABS(ceo_total_comp) peer at $12.3M (Δ $23K heavier vs Scotts Miracle-gro Co); MID · HIGH-MED vs this page's STEEP · HEAVY · PAR-MED.
Vertiv Holdings Co · HEAVY
ABS(ceo_total_comp) peer at $12.3M (Δ $26K lighter vs Scotts Miracle-gro Co); HIGH · LOW-MED vs this page's STEEP · HEAVY · PAR-MED.
Allison Transmission Holdings Inc · HEAVY
ABS(ceo_total_comp) peer at $12.3M (Δ $34K heavier vs Scotts Miracle-gro Co); MID · HIGH-MED vs this page's STEEP · HEAVY · PAR-MED.
BALL Corp · HEAVY
ABS(ceo_total_comp) peer at $12.3M (Δ $45K heavier vs Scotts Miracle-gro Co); STEEP · HIGH-MED vs this page's STEEP · HEAVY · PAR-MED.
Chemicals & Pharmaceuticals benchmark
Scotts Miracle-gro Co stamps STEEP · HEAVY · PAR-MED inside SIC 28 - open the industry median board after the ABS peers.
Pay-ratio rankings · STEEP
See where STEEP · HEAVY packages sit on the national leaderboard after reading Scotts Miracle-gro Co.
Comp structure · HEAVY
Scotts Miracle-gro Co's HEAVY CEO total is equity-sensitive - read what grant-date fair value does and does not mean.
Data sourced from SEC EDGAR DEF 14A for Scotts Miracle-gro Co (CIK 825542), FY2024. See our methodology. Aggregated by PlainCEOPay as of August 2026.
Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.